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deficits by inhibiting microglial MMP-9 expression
after spinal cord ischemia/reperfusion in rats
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Background: Microglia are the primary immune cells of the spinal cord that are activated in response to ischemia/
reperfusion (IR) injury and release various neurotrophic and/or neurotoxic factors to determine neuronal survival. Among
them, matrix metalloproteinase-9 (MMP-9), which cleaves various components of the extracellular matrix in the basal
lamina and functions as part of the blood spinal cord barrier (BSCB), is considered important for regulating inflammatory
responses and microenvironmental homeostasis of the BSCB in the pathology of ischemia. Sevoflurane has been
reported to protect against neuronal apoptosis during cerebral IR. However, the effects of sevoflurane preconditioning
on spinal cord IR injury remain unclear. In this study, we investigated the role of sevoflurane on potential genetic roles of
microglial MMP-9 in tight junction protein breakdown, opening of the BSCB, and subsequent recruitment of microglia to
apoptotic spinal cord neurons.
Results: The results showed significant upregulation of MMP-9 in rats with IR-induced inflammation of the BSCB
compared to that of the sham group, manifested as dysfunctional BSCB with increased Evans blue extravasation
and reduced expression of occludin protein. Increased MMP-9 expression was also observed to facilitate invasion
and migration of activated microglia, imaging as high Iba-1 expression, clustered to neurons in the injured spinal
cord, as shown by double immunofluorescence, and increased proinflammatory chemokine production (CXCL10,
CCL2). Further, sevoflurane preconditioning markedly improved motor function by ameliorating neuronal
apoptosis, as shown by reduced TUNEL-positive cell counts and expression of cleaved caspase-3. These protective
effects were probably responsible for downregulation of MMP-9 and maintenance of normal expression of
occludin protein indicating BSCB integrity from inflammatory damage, which was confirmed by decreased protein
levels of Iba-1 and MMP-9, as well as reduced production of proinflammatory chemokines (CXCL10, CCL2) and
proinflammatory cytokines (IL-1β). Intrathecal injection of specific siRNAs targeting MMP-9 had similar protective
effects to those of sevoflurane preconditioning.
Conclusions: Preconditioning with 2.4% sevoflurane attenuated spinal cord IR injury by inhibiting recruitment of
microglia and secretion of MMP-9; thus inhibiting downstream effects on inflammatory damage to BSCB integrity
and neuronal apoptosis.
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Spinal cord ischemia/reperfusion (IR) injury is a well-
recognized clinical problem resulting in motor and sen-
sory dysfunction that is characterized as temporary or
permanent ischemia of the spinal cord following reperfu-
sion in a setting of shock or thoracoabdominal aorta
surgery [1]. The blood brain barrier (BBB) is a well-
known specialized structure that maintains brain tissue
in an immune-privileged environment [1]. The spinal
cord, as a part of the central nervous system (CNS), con-
nects the brain and the peripheral nervous system. The
blood-spinal cord barrier (BSCB) was presumed to rep-
resent both an anatomical and functional unit mediating
molecular transport and immune regulation. The BSCB,
consisting of a layer of tightly adhering endothelial cells
lining the blood vessel lumen surrounded by astrocytes,
pericytes and perivascular microglia, is critical for the
barrier function by actively and selectively restricting the
passage of water, ions, metabolites, and immune cells
into the spinal cord under physiological and pathological
states [2]. In a previous study using a rat IR model, we
documented that increases in BSCB dysfunction and in-
flammatory reactions play an important role in the evo-
lution of spinal cord IR injury and in the progression of
neuronal damage [3,4]. Furthermore, accumulating evi-
dence suggests that the extracellular matrix and tight
junction complexes serve several important physiological
functions, including defense and homeostatic balance
between the spinal cord and systemic circulation, aber-
rant decomposition of which could cause neurotoxic ef-
fects [5,6]. Treatments that prevent decomposition of
the extracellular matrix and tight junction complexes
after IR may improve the prognosis of patients with
spinal cord IR injury.
Matrix metalloproteinases (MMPs), a family of proteo-
lytic enzymes, influence tissue injury and repair [7,8].
Among multiple nociception-related MMPs, levels of
MMP-9, which is mainly secreted by glial cells, were
markedly increased in cerebral IR models [7]. During
the injury procedure, ischemia-induced oxidative stress
and cytokines increased MMP-9 levels, which ultimately
remodeled microvascular structures of the BBB and led
to an influx of immune or inflammatory cells as well as
subsequent secretion of chemokines and cytokines,
thereby additionally stimulating both proliferation and
recruitment of inflammatory cells into the CNS. There-
fore, this self-sustaining vicious cycle of inflammatory
damage to the BBB is tightly regulated by the expression
of MMPs [8,9]. However, whether or how MMP-9
responds during spinal cord IR injury remains unknown.
Microglia, the primary immune effector cells of the
spinal cord represent an important source of MMPs in
the CNS [9]. They are situated very close to the BSCB to
facilitate their robust activation in response to insultthrough a highly regulated network of cytokines and che-
mokines to subsequently orchestrate immune responses at
sites of injury following BSCB opening [3,4,9,10]. Existing
evidence shows that these extracellular matrix proteins
could be a strong inducer of microglial activation [11],
switching microglia from a resting state into an activated
potentially destructive phenotype characterized by mor-
phological changes, migration, proliferation, phagocytosis,
antigen presentation, and secretion of diffusible factors
including proinflammatory cytokines (such as TNF-α and
IL-1β) [4,10,11]. Moderate activation of microglia is neces-
sary for host defense, whereas over activation of microglia,
together with excess secretion of proinflammatory chemo-
kines and cytokines, is neurotoxic and promotes neuronal
injury [3,10]. Recent papers report that neuronal cell death
causes microglial activation by releasing various signaling
molecules such as the chemokines, gamma interferon-
inducible protein (CXCL) 10 and CC chemokine ligand
(CCL) 2, as well as proinflammatory cytokines (e.g. IL-1β)
and active forms of MMPs [9,12,13]. Thus, modulation of
microglial activation and MMP-9 expression is considered
to be a promising therapeutic strategy for IR injury. One
control mechanism of MMPs is the interaction with
TIMPs (tissue inhibitors of MMPs) [14]. Imbalances
between MMPs and their inhibitors, resulting in excessive
MMP proteolytic activity, are implicated in the pathogen-
esis of neuroinflammation [9,14]. Generally, all MMPs are
inhibited by TIMPs once activated [14,15]. Therefore, we
modulated MMP-9 expression by intrathecal injection of
specific siRNAs targeting MMP-9 to further explore if IR-
induced dysfunction is due to microglial MMP-9 [15].
Sevoflurane is the most widely used volatile anesthetic
for both induction and maintenance of anesthesia in
clinical practice. Mounting evidence indicates that sevo-
flurane preconditioning might induce ischemic tolerance
in the brain and heart, and alleviate hypoxic and ische-
mic injury [16-18]. These findings have triggered an in-
creasing interest in both basic science and clinical
research. Previous studies demonstrate that sevoflurane
can protect against ischemic neuronal damage and
attenuate necrosis and apoptosis through its capacity to
increase cerebral blood flow and preserve cerebral auto-
regulation [19]. However, few studies have attempted to
describe the protective effect of this agent on spinal cord
IR injury [16,20,21]. Therefore, the primary objective of
this study was to investigate whether sevoflurane pre-
conditioning can initiate protective effects on hind limb
motor function and improve the viability of motor neu-
rons in a rat model of transient aortic arch occlusion.
Secondary objectives were to evaluate the correlation of
microglial MMP-9 levels with downstream proinflamma-
tory and apoptotic cytokines, such as CXCL10, CCL2,
IL-1β, and caspase-3, with or without sevoflurane
pretreatment.
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All rats had normal neurological signs before the induc-
tion of ischemia and maintained good health throughout
the experimental period.Sevoflurane preconditioning improved neurological
assessment scores after IR injury
Figure 1A shows the time course of neurological scores
assessed by means of Tarlov scoring system ranged from 0
(paraplegia) to 4 (normal) during 36 h after reperfusion.
There were significant decreases in average Tarlov scores
(relative to baseline) in IR group (P <0.05), suggesting the
development of motor function deficits induced by
14 min of thoracic aortic occlusion. And the average
scores after IR were significantly improved in rats precon-
ditioned with sevoflurane (P < 0.05). When evaluating the
individual score in Figure 1B, each symbol represents for
one rat. Compared with IR group, sevoflurane precondi-
tioning statistically increased the number of rats with high
scores and decreased the number of rats with low scores,
suggesting sevoflurane preconditioning enhanced the re-
covery of neurological deficits (P < 0.05).Figure 1 Effects of sevoflurane preconditioning on neurologic motor
ischemia/reperfusion (IR) injury. (A) Neurological function scores were a
after injury in three groups (n = 24). Neurological function scores ranged fro
SEM. (B) Neurological function scores at 36 h after reperfusion in three gro
(C) Number of intact motor neurons in the ventral gray matter (n = 8). (D)
gray matter stained with hematoxylin and eosin 36 h after reperfusion in th
Nissl substance (arrows), while dead neurons were identified by the presen
vacuolation of gray matter (arrowheads). Upper scale bar = 200 μm; lower sAccording to the results of our preliminary experiment
that sevoflurane preconditioning’s rescue effects on IR-
induced motor neuron dysfunction was probably through
inhibition of MMP-9 upregulation (Additional file 1:
Figure S1). So we also performed functional assays of
MMP-9 with siRNA technology to further confirm the ele-
vated levels of MMP-9 in IR procedure and explore
whether reversing MMP-9 upregulation is one of the key
elements for sevoflurane preconditioning. Similar to the ef-
fects of sevoflurane preconditioning, intrathecal pretreat-
ment with MMP-9 siRNA was observed statistically higher
average and individual Tarlov scores in comparison to
those of IR group during 36 h after reperfusion (P < 0.05).
There were no statistical differences between operated rats
treated with or without control MMP-9 siRNA (P > 0.05).
Sevoflurane preconditioning improved histologic
assessment scores after IR injury
Histopathological changes 36 h after reperfusion are
shown in Figure 1D. Compared that of sham controls, IR
injury resulted in significant loss of motor neurons, as
shown by the presence of diffusely eosinophilic cytoplasms
without cell structure 36 h after surgery (P < 0.05),function and histologic assessment of the spinal cord after
ssessed at 6-h intervals during the 36 h observation using Tarlov scores
m 0 (paraplegia) to 4 (normal). Data are presented as the mean ±
ups. Each symbol represents data for one rat (n = 8, bar = median).
Representative sections of lumbar spinal cords in the ventral horn of
ree groups. Normal neurons exhibited a fine granular cytoplasm with
ce of a diffuse cytoplasm without cellular structure and with extensive
cale bar = 100 μm. **P < 0.05 vs. sham group. ##P < 0.05 vs. IR group.
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cytoplasm and Nissl substance were found in operated-rats
with sevoflurane preconditioning (sevoflurane precondi-
tioning + IR group, S-IR group) (P < 0.05).
Similarly, downregulation of MMP-9 levels by
intrathecal injection of MMP-9 siRNA had a similar
neuroprotective effect to that of sevoflurane precondi-
tioning, as shown by intact neurons comparable to
those of the S-IR group (P > 0.05). Similarly, quantifica-
tion data of intact neurons in spinal cord showed
similar results in Figure 1C.
Sevoflurane preconditioning improved neuronal
apoptosis after IR injury
TUNEL staining is widely used to examine the integrity
of DNA fragmentation as a marker of apoptosis [22].
As shown in Figure 2A, TUNEL assays showed that the
fluorescent spots indicative of cell death mainly corre-
sponded with the distribution of neuronal cell bodies.
Quantitative analysis in Figure 2C showed that the
amount of neuronal apoptosis in the IR group was
significantly higher than that of the S-IR group and that
apoptosis was very minimal in the sham group (P <
0.05). In addition, representative immunohistochemical
analyses were performed to examine the expression of
cleaved caspase-3, a known marker of apoptosis within
neurons, and to investigate the cellular mechanisms by
which treatments might attenuate the development of
neuronal apoptosis [22]. Like the results of TUNEL
staining, representative micrographs showed much
stronger immunoreactivity of cleaved caspase-3 and
more double-labeled neurons in IR group rats than in
sham rats 36 h after injury, suggestive of neuronal
apoptosis after IR. As expected, sevoflurane precondi-
tioning reversed above changes (P < 0.05).
Similar to the effects of sevoflurane preconditioning,
intrathecal pretreatment with MMP-9 siRNA is observed
statistically weaker TUNEL staining and lower immuno-
reactivity of cleaved caspase 3 in neurons in comparison
to those of IR group at 36 h after reperfusion (Figure 2B,
D, P < 0.05). Finally, the same pattern was confirmed in
cleaved caspase-3 protein levels in the spinal cord by
western blot analysis (Figure 2E). There were no statis-
tical differences between operated rats treated with or
without control MMP-9 siRNA (P > 0.05).
Sevoflurane preconditioning attenuated blood spinal cord
barrier leakage
Extravasation of Evans blue (EB) is commonly used to
evaluate the BSCB [9] and is visualized as red under a
fluorescent microscope. As shown in Figure 3A, IR in-
jury caused a marked increase in EB dye extravasation
compared with that of the sham group 36 h after injury
(P < 0.05); while sevoflurane preconditioning rescued thelevels of extravasation following IR, indicating that
sevoflurane preconditioning preserved BSCB integrity.
Additionally, downregulation of MMP-9 levels by intra-
thecal injection of MMP-9 siRNA had comparable ef-
fects on reducing EB extravasation as those observed in
the S-IR group, which was confirmed by quantitative
analysis of EB content and extravasated area in
Figure 3B, C (P > 0.05).
Besides, assessment of water content showed similar
effects in Figure 3D because IR increased water content
due to spinal cord edema closely related to damaged
BSCB integrity. And there were no statistical differences
between groups pretreated with sevoflurane or MMP-9
siRNA (P > 0.05), providing evidence that the neuropro-
tective effects of sevoflurane might result from MMP-9
downregulation.Sevoflurane preconditioning prevented microglia
activation, migration, and upregulation of MMP-9 after IR
injury
Microglia, the resident inflammatory and immune effec-
tors in CNS, migrate into injured sites after insults [23].
To further confirm the relationship of neurons and acti-
vated microglial MMP-9 during IR injury, co-staining
was performed using different protocols 36 h after injury
with the following cell-specific markers: Iba-1 (microglial
marker), NeuN (neuronal marker), and MMP-9. As
shown in our previous study [3] and in Figure 4A,B, ac-
tivated microglia with a macrophage-like morphology
expressed high levels of Iba-1 36 h after IR injury.
MMP-9 with the identical fluorescent label colocalized
with the distribution of Iba-1-positive cells in the IR
group. This was attenuated by preconditioning with
sevoflurane or intrathecal injection of MMP-9 siRNA,
although not in cells of the sham-operated animals (P <
0.05). Similar quantification of MMP-9 colocalization
with Iba-1-positive cells (Figure 4D) confirmed that in-
creased MMP-9 secreted by microglia was involved in
IR-induced spinal cord injury.
Furthermore, when compared with those of the sham
group, cells with robust Iba-1 immunoreactivity promin-
ently surrounded neurons in the laminae of the spinal
cord ventral horn 36 h post-IR injury; sevoflurane pre-
conditioning inhibited the number of Iba-1-positive
microglia and their migration to neurons (Figure 4C,
44.34 ± 8.73 versus 68.25 ± 12.06, P < 0.05). As expected,
intrathecal treatment with MMP-9 siRNA had similarly
inhibitory effects to those of sevoflurane preconditioning
on the activation and migration of microglial cells
(47.32 ± 7.34 versus 44.34 ± 8.73, P > 0.05), suggesting a
close functional relationship between neuronal and
microglial activation and increased MMP-9 expression
in the injured region.
Figure 2 Effects of sevoflurane preconditioning on neuronal apoptosis after spinal cord ischemia reperfusion (IR) injury. (A)
Representative micrographs of TUNEL staining (green) and DAPI (blue) in laminae IX of the ventral gray matter at 36 h after IR injury. Scale bars
are 200 μm. (B) Representative immunohistochemical localization of neurons (NeuN; green) and cleaved-caspase-3 (red) in laminae IX of the
spinal cord at 36 h after IR injury. Arrows delineate colocalization. Scale bars are 100 μm. Immunohistochemistry data showing that IR led to a
decrease in neuronal number in the spinal ventral horn and an increased percentage of NeuN/cleaved-caspase-3-positive cells, suggesting the
loss of neurons is partly a result of apoptosis. Pretreatment with sevoflurane and downregulation of MMP-9 by intrathecal injection of MMP-9 siRNA
had neuroprotective effects reflected in decreased neuronal apoptosis. (C) Quantification of TUNEL-positive neurons in laminae IX of the ventral horn
as averaged across three independent experiments. (D) Quantification of colocalized cells (cells with yellow signals) in laminae IX. (E) Representative
western blot and quantitative protein analysis of cleaved caspase-3 in the spinal cord 36 h after surgery. Relative integral density values (IDVs) were
calculated after normalizing to the sham group in each sample. All data are presented as mean ± SEM (n = 8 per group). **P < 0.05 vs. sham group;
##P < 0.05 vs. IR group.
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Figure 3 Effects of sevoflurane preconditioning on blood-spinal cord barrier (BSCB) integrity after spinal cord ischemia reperfusion (IR)
injury. (A) Effects of spinal cord IR injury on BSCB permeability measured by EB extravasation. Almost no red fluorescence was observed in the
spinal cord of sham group rats 36 h after injury. Much more red fluorescence, especially in the gray matter, was observed in IR group rats 36 h
after injury, whereas EB red extravasation was significantly less in the sevoflurane preconditioning group. Further, downregulation of MMP-9 by
intrathecal injection with MMP-9 siRNA had similar neuroprotective effects on the integrity of the BSCB to those of sevoflurane preconditioning.
(B) EB content of the spinal cord (μg/g). (C) Percentage of EB extravasated area. (D) Quantification of the water content of the spinal cord
(edema). All data are presented as mean ± SEM (n = 8 per group). Scale bars are 200 μm. **P < 0.05 vs. sham group; ##P < 0.05 vs. IR group.
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results in reduced expression of MMP-9, proinflammatory
chemokines and cytokines after IR injury
MMP-9 facilitates migration of microglia by disrupting
the extracellular matrix and also modulates inflamma-
tory reactions by cleaving inflammatory cytokines and
chemokines [23,24]. To test whether sevoflurane precon-
ditioning modulates the inflammatory response through
regulation of microglial activation and secretion of
MMP-9, we analyzed levels of Iba-1 and MMP-9 in in-
jured spinal cords by western blot analysis and, in the
case of CXCL10, CCL2, and IL-1β, by ELISA. Represen-
tative immunoblots and quantification (Figure 5A and B)
showed that IR induced substantial increases in Iba-1
levels and secretion of MMP-9 in the spinal cord 36 h
after IR surgery compared with those of sham-operated
controls; whereas, significant decreases in the expression
of Iba-1 and MMP-9 were detected in rats receiving
sevoflurane preconditioning or intrathecal pretreatment
with MMP-9 siRNA (P < 0.05). Meanwhile, spinal cord
levels of proinflammatory chemokines (CXCL10 and
CCL2) and cytokines (IL-1β) had similar expression pro-
files (Figure 5C-E, P < 0.05). There were no statistical
differences between groups pretreated with sevoflurane
or MMP-9 siRNA (P > 0.05), suggesting that sevoflurane
preconditioning regulated the inflammatory response byreducing microglial activation and the secretion of
MMP-9.
Discussion
Physical damage to the spinal cord after ischemia/reper-
fusion (IR) injury is accompanied by increased blood
spinal cord barrier (BSCB) permeability, followed by
neuronal apoptosis, glial activation, and prolonged neu-
roinflammatory responses [6,14,25]. Considerable efforts
have been directed at increasing ischemic tolerance in
the spinal cord in both experimental animals and
humans in order to decrease the incidence of paraplegia.
Unfortunately, current therapies remain unsatisfactory
and surgical management is still the main choice of
treatment [4,6,26]. Sevoflurane, a volatile anesthetic with
the unique clinical characteristics of rapid recovery time
with little emergence agitation, is suitable for both in-
duction and maintenance of anesthesia and as a result is
the most frequently used anesthetic, clinically. Neuro-
protective effects of sevoflurane preconditioning have
been reported in several models of cerebral ischemia
and are attributed to its capacity to increase cerebral
blood flow for autoregulation [16,18,19]. Given the bene-
fits of volatile anesthetic preconditioning in improving
myocardial functional recovery and reduced infarct size
after ischemia [17,27], we explored the therapeutic
Figure 4 (See legend on next page.)
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Figure 4 Effects of sevoflurane preconditioning on microglia activity, migration, and secretion of MMP-9 after spinal cord ischemia
reperfusion (IR) injury. (A) Representative micrographs of the cellular location of MMP-9 (green) with antibodies against a microglial specific
marker (Iba-1; red) 36 h after IR injury. Arrows delineate colocalization. A low magnification view showed fewer double-labeled cells in the spinal
dorsal horn of rats preconditioned with sevoflurane or treated by intrathecal injection of MMP-9 siRNA. Arrows delineate colocalization. Scale bars
are 100 μm. (B) Higher magnification image confirming that MMP-9 (with the identical fluorescence label) colocalized with Iba-1-positive cells
36 h after IR injury. Scale bars are 100 μm. (C) Distribution of Iba-1-positive cells in spinal lamina IX after IR injury. Representative micrographs
showed that the IR-induced increase in Iba-1 immunoreactivity was prominently surrounded by NeuN-positive cells. Sevoflurane preconditioning
prevented this redistribution. Similar neuroprotective effects were observed after downregulation of MMP-9 by intrathecal injection of MMP-9
siRNA. This suggests that the neuroprotective effects of sevoflurane preconditioning, in part, contributed to the inhibition of residual immune cell
(microglia) activation and MMP-9 expression in the injured region. (D) Histogram for quantification of colocalized cells (cells with yellow signals).
(E) Histogram for quantification of Iba-1-positive cells localized around NeuN-positive cells of lamina IX. All data are presented as mean ± SEM
(n = 8 per group). **P < 0.05 vs. sham group; ##P < 0.05 vs. IR group.
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injury to induce a “preconditioned state” upon IR injury.
Consistent with previous research in our laboratory
[16,19], the present study demonstrated that spinal cord
IR injury induced by 14-min aortic arch occlusion pro-
duced extensive neuronal apoptosis manifesting as se-
vere hind-limb motor functional deficits, along with
increased BSCB leakage. Sevoflurane preconditioning
1 h prior to ischemia led to significant improvements in
BSCB integrity and motor function due to decreased
microglial activation resulting in reduced expression of
MMP-9, proinflammatory chemokines (CXCL10 and
CCL2), and cytokines (IL-1β) after IR injury. In parallel
with the role of sevoflurane preconditioning in the
course of IR, we found similar profiles in rats intra-
thecally pretreated with siRNA, suggesting that sevoflur-
ane regulates MMP-9-evoked pronociceptive actions
after IR. These results confirm and extend previous
studies of preconditioning induced by volatile anesthetic
agents [17-20].
Microglial cells are key responders to neural infarcts
and play a central role in regulating the pathogenesis of
IR injury [3,4,10,28]. As the resident macrophages of the
spinal cord, they retract and thicken their cellular pro-
cesses to transform into an amoeboid form within
30 min of neural insult and migrate toward vulnerable
areas to confine the lesion and are capable of phagocyt-
osis [3,7,11,28]. However, some studies suggest that
microglia activation has both positive and negative ef-
fects in various neurological models and conditions [28].
In addition to releasing neurotrophic factors, activated
microglial cells also secrete various pro-inflammatory
cytokines, nitric oxide, and other factors that can aggra-
vate injury [3,11,28,29]. How the specific timing and ex-
tent of microglial activation might affect these
deleterious versus beneficial consequences for spinal
cord recovery remains a controversial topic. Karwacki Z
and colleagues reported that sevoflurane in concentra-
tions of 1 and 2 MAC (minimum alveolar concentration)
inhibited ischemia-induced polymorphonuclear neutro-
phil (PMN) adhesion. With similar immunophenotypicalfeatures as those of PMN, sevoflurane was demonstrated
to modulate microglial adhesion [30]. Herein, we used
Iba-1 as cellular marker of microglia and analyzed
microglial activation qualitatively and quantitatively. Our
data show that after IR injury, microglia were rapidly ac-
tivated in IR group rats, as cells were intensely stained
with Iba-1 antibody and possessed enlarged and vacuo-
lated cell bodies extending stout processes (Figure 4A).
Sevoflurane preconditioning markedly prevented in-
creases in Iba-1 protein expression (Figure 5A), com-
pletely consistent with the results of Karwacki Z and
colleagues [30].
In case of IR, infiltration and migration of microglia
into the spinal cord have been linked with injury to the
neurovasculature caused by substances released from ac-
tivated microglia, namely matrix metalloproteinases
(MMPs) [7,14]. MMPs are capable of degrading extracel-
lular matrix components and are responsible for promo-
tion of BSCB opening [9,14,30]. Among MMPs, MMP-9
has been reported to be the most abundant inducible
factor in the pathology of ischemia in several previous
studies [8,9,11,31] including our rabbit IR model [6]. In
the present study, we also found that fluorescently la-
beled MMP-9 colocalized with Iba-1-positive cells in the
injured spinal cords of rats subjected to IR injury, and
sevoflurane preconditioning prevented the increased
number of such double-labeled microglia (Figure 4A).
Correspondingly, western blot analysis (Figure 5A) con-
firmed the results of the immunofluorescence analysis.
Representative immunoblots showed that reduced
MMP-9 protein expression was associated with low
expression of Iba-1, 36 h after surgery. These results
were consistent with the study of Matsmumoto and col-
leagues [32], who also found that the initial changes in
MMP activity could be detected as early as 15 min after
insult and persisted for up to 48 h; a time frame that
exactly coincides with the morphological and functional
changes of microglia [12,32]. As expected, in the present
study, intrathecal infusion of MMP-9 siRNA had a
suppressive effect on the number of double-labeled acti-
vated microglia and on MMP-9 activity. In addition to
Figure 5 Effects of sevoflurane preconditioning on proinflammatory chemokines and cytokines and neuronal apoptosis after spinal
cord ischemia reperfusion (IR). (A-B) Representative western blot and quantitative protein analysis of Iba-1 and MMP-9 in the spinal cord 36 h
after surgery. Relative integral density values (IDVs) were calculated after normalizing to the sham group in each sample. (C-E) Quantification of
CXCL-10, CCL2, and IL-1β production in the spinal cord 36 h after IR injury, as assessed by ELISA. Sevoflurane preconditioning prevented IR-
induced microglial activation and significant increases in the products of proinflammatory chemokines (CXCL10 and CCL2) and cytokines (IL-1β)
36 h after IR injury. Similar anti-inflammatory effects were observed after intrathecal injection of MMP-9 siRNA. All data are presented as mean ±
SEM. **P < 0.05 vs. sham group; ##P < 0.05 vs. IR group.
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apoptotic and anti-inflammatory effects in various
models [8,9,32-34]. It is well known that apoptosis is
one of the major mechanisms that leads to cell death
after IR. After ischemia, DNA fragmentation and chro-
matin condensation function as pro-apoptotic signalsthat trigger caspase activation [22,25,26]. The present
study also demonstrated that sevoflurane precondition-
ing influences motor function by likely inhibiting infil-
tration and migration of microglia to injured neurons, in
accordance with the phenomena described by Choi MS
and colleagues that microglia, the resident effectors of
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inflammation after insults [23]. Moreover, we performed
TUNEL staining and measured protein levels of cleaved
caspase-3, a known marker of apoptosis within neurons,
to investigate the mechanisms by which sevoflurane
might attenuate the development of neuronal apoptosis
after IR (Figure 2A, B). The data showed that TUNEL-
positive cells mainly displayed a neuronal morphology
and were distributed in the lamina of the anterior horn
with increased cleaved caspase-3 immunoreactivity,
which were further confirmed by similar changes in
caspase-3, Iba-1, and MMP-9 protein levels observed in
western blots. Furthermore, downregulation of MMP-9
expression by intrathecal pretreatment with siRNA had
similar anti-apoptotic effects as those of sevoflurane pre-
conditioning, suggesting that microglia produce the ma-
jority of MMP-9 in response to IR injury, ultimately
leading to neuronal apoptosis and motor function
impairments.
In regard to inflammation, MMP-9 facilitates migra-
tion of inflammatory cells by cleaving inflammatory cy-
tokines and chemokines in several inflammatory
diseases, such as Alzheimer's disease, Parkinson disease,
and multiple sclerosis, or after stroke or spinal cord
trauma [23]. CXCL10 and CCL2 are involved in blood
cell and PMN chemotaxis [13,35–37]. Moreover, a few
studies also have reported that CXCL10 and CCL2 were
chemokines that acted as potent recruiters with their
primary effects on the innate immune system via
chemotaxis residual microglia during peripheral and
CNS inflammation [35,36,38]. Our study suggests that
IR-induced upregulation of MMP-9 expression drives
production of proinflammatory chemokines (CXCL10
and CCL2) and cytokines (IL-1β) that in turn amplify in-
flammatory responses, which ultimately promote neur-
onal apoptosis leading to hind-limb motor dysfunction
[23,37]. Thus, decreased expression could contribute to
reduced infiltration or migration of resident microglia of
the spinal cord, leukocytes, and other proinflammatory
cells in circulation through the disrupted BSCB, thereby
ameliorating the inflammatory response [35-37,39]. Not-
ably, prophylactic administration of neutralizing anti-
bodies against CXCL10 and CCL2 prevents microglial
infiltration, decreases neuronal loss, and improves be-
havioral recovery from spinal cord injury [37]. Further,
in support of the above hypothesis, intrathecal pretreat-
ment with specific siRNAs targeting MMP-9 had similar
effects on reducing the release of chemokines (CXCL10
and CCL2) and products of proinflammatory cytokines (
IL-1β) leading to decreased neuronal loss and improved
behavioral recovery from spinal cord injury (Figures 2
and 4). This inhibition by MMP-9 siRNA may limit the
extent of BSCB disruption as well as the extent of
microglial activation and progressive recruitment to thespinal cord, which correlated with caspase 3 expression
and inflammation-mediated neuronal loss [15]. One the
basis of published work, IL-1β is well-recognized as pro-
inflammatory proteins that are associated with activated
microglia [3,4,35]. Meanwhile, IL-1β is activated via
cleavage from its precursor by caspase-1 (the IL-1β con-
verting enzyme), as well as by other enzymes such as
MMP-9 and MMP-2 [15]. Consistent with previous
studies, the data in Figure 5 also show that IL-1β expres-
sion was increased in the spinal cord in a microglial
activity-dependent manner during the course of IR
[4,10]. Intrathecal MMP-9 siRNA treatment abrogated
the increase in IR-induced IL-1β content, suggesting that
IL-1β activation was a downstream mechanism under-
lying MMP-9-induced neuroinflammation accompanied
by microglial activation [13]. Thus, it is conceivable that
MMP-9 might antagonize these inflammatory factors via
inhibiting the release of chemokines (CXCL10 and
CCL2) and proinflammatory cytokines (IL-1β), which is
in agreement with recent studies by Kjell J and Huang
CY [38,40]. They further suggested that neurons and
microglia form a highly interdependent network that is
now considered to be the functional unit of the CNS. Al-
though it is unknown whether microglia are the first re-
sponders to injury or respond to an “emergency signal”
from neurons, it is conceivable that neuronal apoptosis
following IR injury combined with extracellular microen-
vironmental imbalances might be the major stimuli for
microglial activation [4,28,31]. All the above evidence,
when considered together, suggests that upon IR-
induced activation, microglia express increased CXCL10,
CCL2, and other chemotaxis-associated molecules,
which leads to the recruitment of inflammatory cyto-
kines to the lesional area, resulting in amplified activa-
tion of additional spinal cord-derived microglia leading
to neuronal loss. Blocking this pathological sequence by
sevoflurane preconditioning had beneficial effects on
BSCB integrity and hind-limb functional recovery.
Nevertheless, it's worth noting that that the neuropro-
tective effects of sevoflurane preconditioning against
spinal ischemia is very complicated. Some other under-
lying mechanisms such as activation of extracellular
signal-regulated kinase or potassium ATP channel, as
well as through free radicals-mediated up-regulation of
antioxidant enzymes were also demonstrated to play a
role [16-18,26,41]. Further studies focused on the links
between different actions of sevoflurane preconditioning
still need to be conducted.
In conclusion, the current study provides the first dir-
ect evidence that sevoflurane preconditioning produces
anti-inflammatory and anti-apoptotic effects on spinal
cord IR injury in rats. We provide additional evidence
that this effect is possibly mediated through the inactiva-
tion of microglia resulting in reduced expression of
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kines. These data suggest that sevoflurane precondition-
ing may provide a new practical method for protecting
against perioperative spinal cord IR injury.
Materials and methods
Experimental animals and protocols
The study was performed in accordance with the Guide
for the Care and Use of Laboratory Animals (U.S. Na-
tional Institutes of Health publication No. 85–23, National
Academy Press, Washington DC, revised 1996). The ex-
perimental protocol was approved by the Animal Care
and Use Committee of China Medical University. Male
Sprague–Dawley rats, weighing between 200 and 250 g,
and neurologically intact before anesthesia were used in
our experiment. Rats were acclimatized for at least 7 days
prior to the operation and were bred in standard cages on
a 12 h light/dark cycle with free access to food and water.
Seventy-two male SD rats were assigned by means of a
random number table to receive either 33% oxygen or
sevoflurane preconditioning (33% oxygen + 1 MAC sevo-
flurane) for 1 h, followed by a 30-min washout. The sham
group rats were subjected to sham operations without IR
injury. The IR group rats were subjected to a 14-min oc-
clusion of the aortic arch followed by reperfusion. Sevo-
flurane preconditioning + IR group rats (S-IR) were
pretreated with inhalation of sevoflurane before induction
of IR injury. In parallel, IR +MMP-9 siRNAs or control
RNA group rats (Si-IR or Con-IR) were intrathecally
injected with 5 μg MMP-9 siRNA or control RNA (Jima
Inc., Shanghai, China) at a concentration of 1 μg /μL once
a day starting 2 days before ischemia. The sequences of
these siRNAs were as follows. MMP-9 siRNA: 5′-GAC
UUGCCGCGAGACAUGAtt-3′ (forward), 5′-UCAUGU
CUCGCGGCAAGUCtt-3′ (reverse); control RNA: 5′-GA
CUUCGCGGGACACAUGAtt-3′ (forward), 5′-UCAUG
UGUCCCGCGAAGUCtt-3′ (reverse) [15].
Sevoflurane preconditioning and surgical procedures
Preconditioning with sevoflurane was performed as previ-
ously described [17]. In brief, rats were exposed to 2.4%
sevoflurane in a 33% oxygen and air mixture by breathing
spontaneously through a nonsealing facemask device. The
end-tidal sevoflurane concentration in expired gas was
continuously monitored and maintained at 1 MAC (2.4–
2.7%) with a gas analyzer (Capnomac Ultima; Datex,
Helsinki, Finland) for 1 h. In all groups, rectal temperature
was measured and maintained at 37.0 ± 0.5°C with a heated
operating table. Rats were anesthetized by intraperitoneal
injection of 4% sodium pentobarbital at an initial dose of
50 mg/kg after 2 h. The spinal cord IR model was induced
by occlusion of the aortic arch for 14 min, as previously re-
ported [42]. The aortic arch was exposed through a cervi-
cothoracic approach. Under direct visualization, the aorticarch was cross-clamped between the left common carotid
artery and the left subclavian artery. A catheter was
inserted into the left carotid artery and into the tail artery
to measure proximal and distal blood pressure. Ischemia
was confirmed as a 90% decrease in flow measured at the
tail artery using a laser Doppler blood flow monitor (Moor
Instruments, Axminster, Devon, UK) for 14 min, after
which, the clamp was removed and reperfusion was
performed for 36 h. Sham operation rats underwent the
same procedure, but no occlusion of the aortic arch was
performed. All rats were allowed to recover in a plastic box
at 28°C for 4 h and were subsequently placed in separate
cages with free access to food and water. Rats were eutha-
nized 36 h after the surgical procedure.
Neurologic assessment
After reperfusion, neurologic function was quantified by
two observers who were blinded to the experimental
procedures at a 6 h interval during a 36 h observation
period using a Tarlov scoring system, as follows: 0 = no
lower limb function; 1 = perceptible lower limb function
with weak antigravity movement only; 2 = some move-
ment of lower limb joints with good antigravity strength,
but inability to stand; 3 = ability to stand and walk, but
not normally; and 4 = normal motor function [40].
Hematoxylin and eosin staining
All rats were anesthetized with an overdose of pentobar-
bital 36 h after IR injury and the L4–L6 segments of
spinal cords were rapidly collected for analysis because
of their vulnerability to ischemic injury. Tissue was fixed
in 4% paraformaldehyde and embedded for hematoxylin
and eosin (HE) staining. Stained sections were examined
under a microscope by two observers unaware of the
grouping and outcomes (Olympus reflected and visual
communication system, Olympus, Japan) to judge the
morphological appearance of neurons. Normal neurons
were defined as viable by the presence of basophilic stip-
pling (containing Nissl substance), whereas necrotic or
dead neurons were identified by the presence of a dif-
fusely eosinophilic cytoplasm with pyknotic homogenous
nuclei, according to our previously validated protocol
[16]. Data were calculated as the mean number of intact
neurons per area in three sections for each rat.
Blood spinal cord barrier leakage evaluation
At 12 h and 36 h after IR injury, EB content and EB
fluorescence were used for quantitative and qualitative
examination of BSCB integrity, as previously described
[9,12]. Briefly, 30 g/L (45 mg/kg; Sigma) EB was slowly
administered in the tail vein 60 min before sacrificing
the animals. After soaking the tissues in methanamide
for 36 h (60°C) and centrifugation, the absorption of the
supernatant was detected at 632 nm and reported as the
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travasation. In addition, the tissue was fixed in 4% parafor-
maldehyde (PFA), then sectioned (10 μm) and visualized
using a BX-60 (Olympus, Melville, NY) fluorescence
microscope (green zone) for fluorescence measurements.
Double immunofluorescence
To measure the expression of MMP-9 in microglia,
double immunofluorescence staining of MMP-9 and the
microglia marker Iba-1 was performed as described pre-
viously [3,4,11]. Briefly, the spinal cord was fixed and
sectioned into 10-μm slices with a Leica CM3050 S
cryostat. Sections were blocked with 10% bovine serum
albumin (BSA) for 1 h at room temperature and incu-
bated overnight at 4°C with primary antibodies: rabbit
anti-Iba-1 antibody (1:800, Wako, 019–19741) together
with mouse anti-MMP-9 (1:200, Abcam 58803) or
mouse anti-neuronal specific nuclear protein (NeuN,
1:500; Abcam 104224). After incubation for 2 h at room
temperature with the corresponding secondary anti-
bodies: Alexa 488-conjugated donkey anti-rabbit IgG
(1:500, Molecular Probes, Rockford, USA) and Alexa
594-conjugated donkey anti-mouse IgG (1:500, Molecu-
lar Probes), sections were incubated with 4′,6-diami-
dino-2-phenylindole (DAPI; 1:500000; Abcam 104139)
for 10 min at room temperature before cover slipping.
Sections were examined and imaged with a Leica TCS
SP2 (Leica Microsystems, Buffalo Grove, IL, USA) laser
scanning spectral confocal microscope.
TUNEL assay
A TUNEL (terminal deoxynucleotidyl-transferase-
mediated dUTP nick-end labeling) assay is the most
commonly used technique for examining apoptosis via
DNA fragmentation. In situ detection of apoptosis in
spinal cords was performed through staining using an
ApopTag® Fluorescein In Situ Apoptosis Detection Kit
(EMDMillipore, S7110) to modify genomic DNA utiliz-
ing terminal deoxynucleotidyl transferase (TdT), accord-
ing to the manufacturer’s instructions. After TUNEL
labeling, cell nuclei were labeled with DAPI (1:500000;
Abcam 104139), and examined under a laser scanning
spectral confocal microscope by two independent ob-
servers. Average numbers of TUNEL-positive motor
neurons in the anterior spinal cord of the three sections
were counted for comparisons among the groups.
Western blot analysis
Expression of MMP-9 and NF-κB in spinal cord tissue
was determined by western blot analyses. Rat spinal
cords were homogenized and total proteins were puri-
fied using cell and tissue protein extraction reagents ac-
cording to the manufacturer’s instructions (KC-415;
Kang Chen, Shanghai, China). The antibodies used forwestern blotting were mouse monoclonal anti-Iba-1
(1:800, Abcam 15690), rabbit polyclonal anti-MMP-9
(1:500, Abcam 38898), and rabbit monoclonal anti-
cleaved caspase-3 (1:500, Abcam32351), with horserad-
ish peroxidase-conjugated secondary antibodies (Bioss,
Beijing, China) for the corresponding species. Blots were
also probed with rabbit monoclonal anti-GAPDH
(1:1000; Abcam 8245) as a loading control.
ELISA analysis
Spinal cords were collected, homogenized, and centri-
fuged to obtain tissue for ELISA. Chemokine (CXCL10
and CCL2) and proinflammatory cytokine (IL-1β) con-
tent were determined using ELISA kits (Pharmingen,
San Diego, Calif; R&D Systems, Minneapolis, MN, US).
According to the manufacturers’ instructions, absorb-
ance (A) was quantified at λ = 450 nm. The IL-1β con-
tent of each sample was calculated based on a standard
curve. CXCL10, CCL2, and IL-1β concentrations were
expressed in pg/mg protein.
Statistical analysis
All data were expressed as means ± standard error of the
mean (means ± SEM) and analyzed by SPSS software
(version 17.0, SPSS Inc, Chicago, IL, USA). All variables
measured in this study were normally distributed.
Groups were compared with Student’s t-test or one-way
analysis of variance (ANOVA), followed by Newman-
Keuls post-hoc analysis. A P value of <0.05 was consid-
ered statistically significant.
Additional file
Additional file 1: Figure S1. Effects of sevoflurane preconditioning on
MMP-9 expression in the spinal cord after ischemia reperfusion (IR). (A)
Representative western blot and quantitative protein analysis of MMP-9 in
the spinal cord 36 h after surgery. Relative IDVs were calculated after
normalizing to the sham group in each sample. (B) Real-time PCR analysis
was performed in duplicate for MMP-9 under study. All data are presented
as mean ± SEM. **P < 0.05 vs. sham group; ##P < 0.05 vs. IR group.
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